Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Omeprazole/antacids swallowable tablet - Salix Pharmaceuticals

Drug Profile

Omeprazole/antacids swallowable tablet - Salix Pharmaceuticals

Alternative Names: Magnesium hydroxide/sodium bicarbonate/omeprazole; Omeprazole/antacids; Sodium bicarbonate/omeprazole/magnesium hydroxide; Zegerid swallowable tablets

Latest Information Update: 14 Jan 2014

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Santarus
  • Developer Salix Pharmaceuticals
  • Class 2 pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Gastric antisecretories; Small molecules
  • Mechanism of Action Antacids; Proton pump inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Gastrointestinal disorders; Heartburn

Most Recent Events

  • 02 Jan 2014 Santarus has been acquired and merged into Salix Pharmaceuticals
  • 31 Oct 2011 Norgine completes a phase III trial in Heartburn in Poland (NCT01493089)
  • 08 Sep 2011 Norgine completes a phase III trial in Heartburn in Bulgaria, Czech Republic, UK and Hungary (EudraCT 2010-022082-10)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top